Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

37 results about "Chromosome microdeletion" patented technology

Amplification composite for detecting microdeletion of Y-chromosome and detection kit

The invention relates to amplification composite for detecting the microdeletion of Y-chromosome and a detection kit, belonging to the field of biotechnical detection. The amplification composite for detecting the microdeletion of Y-chromosome can be amplified to as many as 30 sites related to the microdeletion detection of the Y-chromosome through one reaction. The detection kit detects the microdeletion of the Y-chromosome through the quantitative fluorescent PCR (Polymerase Chain Reaction) method by using the amplification composite. The microdeletion abnormality of the Y-chromosome is determined according to the existence of an amplification product and the quantity of the amplification product. A large quantity of sites enables the detection result to be more convincible and can provide much more and more detailed information for determining the deletion type, and the quantitative detection of partial deletion and repetition can be realized. The detection kit is easier and more convenient to operate, only one PCR amplification and one sequencer detection reaction are needed to complete the detection of one sample, the whole process needs 4-5 h, and the operation intensity and the detection time are greatly reduced.
Owner:BEIJING MICROREAD GENE TECH

Method for detecting chromosome microdeletion and micro-duplication of human embryo

The invention relates to a method for detecting chromosome microdeletion and micro-duplication of a human embryo. The method comprises the following steps of performing whole genome amplification on cells cultured in vitro, interrupting DNA (deoxyribonucleic acid) molecules, and sequencing DNA fragments to obtain sequencing reads; comparing the sequencing reads with a reference sequence, and positioning the sequencing reads on the reference sequence; screening non-repeated areas of the reference sequence, and reserving the non-repeated areas; establishing a matrix of read number in windows through normal samples, analyzing the data of the normal samples, performing statistics on the read number of all the windows in the non-repeated areas, and establishing a probability matrix of the read number and chromosome enpeoids; calculating the copy number, i.e., the A/B/C state, of loci; selecting m continuous loci, i.e., the A state, as micro-duplication loci, and selecting m continuous loci, i.e., the C state, as microdeletion loci; contrasting the micro-duplication loci and the microdeletion loci with the existing CNV (copy number variation) and disease database, performing basic gene annotation and gene function analysis which relates to deletion parts, and annotating with a microdeletion syndrome disease type.
Owner:BEIJING ZHONGYI KANGWEI MEDICAL INSTR

Molecular combination probe for diagnosing and screening chromosome microdeletion syndrome

The invention belongs to the technical field of biology, and particularly relates to a molecular combination probe for diagnosing and screening chromosome microdeletion syndrome. The molecular combination probe is used for selecting the key gene of the Williams syndrome, the 22q11 microdeletion syndrome, the Prader-Willi syndrome, the Angelman syndrome, the 15q13.3 microdeletion syndrome and the Rett syndrome, or the gene within a critical area, or the gens arranged at two ends within a duplication/deletion fragment, selecting the sequence which meets a corresponding condition as a probe sequence according to the sequence of the gene, and adding a general primer sequence and adding a phosphorylation mark to the 5'end of a probe left-half sequence and the 3'end of a right-half probe to prepare the combination probe for the multiple continuous probe amplification technology. According to the combination probe provided by the invention, the defects of the fluorescent quantitative PCR (polymerase chain reaction) can be overcome, a plurality of sequences can be analyzed for once, and the molecular combination probe is higher in resolution ratio, sensitivity and repeatability. The probe can be used for the clinical molecular diagnosing and screening of the six-chromosome microdeletion syndrome.
Owner:FUDAN UNIV

Probe combination and kit for detecting microdeletion and microrepetition of Y chromosome and application of probe combination and kit

PendingCN114015787AConsistent target specificitySame hybridization conditionMicrobiological testing/measurementDNA/RNA fragmentationY chromosome microdeletionChromosome microdeletion
The invention relates to the field of chromosome variation detection, in particular to a probe combination and a kit for detecting microdeletion and microrepetition of a Y chromosome and application of the probe combination and the kit, and the probe combination comprises specific probes aiming at 25 detection points (6 basic points and 19 extension points) of the Y chromosome. When the probe combination provided by the invention is adopted for detection, only Y chromosome microdeletion and microrepetition, 25 point locations, variation interval range judgment and related gene judgment are needed to be simultaneously detected aiming at DNA to be detected in the same reaction tube, and a qualitative and quantitative method containing 6 basic point locations and 19 expansion point locations is adopted. The technical means can be applied to various specimens such as semen, peripheral blood, tissues and the like, and the sample size is required to be only 20-50ngDNA (Deoxyribose Nucleic Acid); the method is short in detection time, economical, simple and convenient, capable of reducing manual operation errors, suitable for various types of samples, visual and accurate in structure interpretation and easy to popularize.
Owner:王晴雪

Azoospermia chromosome variation detection kit

The invention belongs to the technical field of biological detection, and discloses an azoospermia chromosome variation detection kit. According to the invention, on the basis of retrospective analysis of detection results of chromosome karyotype and Y chromosome microdeletion of patients suffering from azoospermia and establishment of an azoospermia genetic database in China, a multiplex fluorescent quantitative PCR method is adopted to establish a primer probe and a kit for realizing azoospermia chromosome variation detection at one time, the clinical male infertility reason detection efficiency is improved, the cost is reduced, and the period is shortened; meanwhile, the research specially aims at Chinese populations, the clinical actual requirements of China are better met, and the positive detection rate is increased. The cause of male infertility is determined from the molecular level, so that unnecessary treatment is avoided, and the problem that the clinical mutation deletion rate of male offspring is increased due to the application of ICSC is reduced. In addition, the most advanced drying technology is adopted, the detection sensitivity can be improved, the clinical detection process is simplified, and actual use and popularization are more convenient.
Owner:BEIJING CHAOYANG HOSPITAL CAPITAL MEDICAL UNIV +1

Amplification composite for detecting microdeletion of Y-chromosome and detection kit

The invention relates to amplification composite for detecting the microdeletion of Y-chromosome and a detection kit, belonging to the field of biotechnical detection. The amplification composite for detecting the microdeletion of Y-chromosome can be amplified to as many as 30 sites related to the microdeletion detection of the Y-chromosome through one reaction. The detection kit detects the microdeletion of the Y-chromosome through the quantitative fluorescent PCR (Polymerase Chain Reaction) method by using the amplification composite. The microdeletion abnormality of the Y-chromosome is determined according to the existence of an amplification product and the quantity of the amplification product. A large quantity of sites enables the detection result to be more convincible and can provide much more and more detailed information for determining the deletion type, and the quantitative detection of partial deletion and repetition can be realized. The detection kit is easier and more convenient to operate, only one PCR amplification and one sequencer detection reaction are needed to complete the detection of one sample, the whole process needs 4-5 h, and the operation intensity and the detection time are greatly reduced.
Owner:BEIJING MICROREAD GENE TECH

A composition of primers and probes for detecting y-chromosomal microdeletion, a detection method and a kit for non-diagnostic purposes

The invention belongs to the technical field of biological detection, and discloses a composition of primers and probes for detecting Y chromosome microdeletion, a non-diagnostic detection method and a kit. The sY1324, sY127, sY1192, sY85, sY1233, sY254 loci and the SRY gene in the three regions of AZFa, AZFb and AZFc are selected for simultaneous detection, which can identify different deletion types of the Y chromosome, adding the AZFc region b2 / b3, b1 / b3 and b2 / b4 deletion detection rates. The kit only uses nucleic acid amplification reaction A and nucleic acid amplification reaction B, and the combination of the two reactions can realize the detection, breaking through the limitations of the traditional 6-site detection method, improving the positive detection rate and accuracy, and the low cost of reagents, which promotes Domestic independent research and development products have reached the international leading level. Detection by fluorescent quantitative PCR method has high detection efficiency and sensitivity, is convenient, has low requirements for detection equipment and operators, and is convenient for large-scale promotion. Quality control can be carried out for sample extraction, PCR amplification and manual operation throughout the detection process.
Owner:BEIJING CHAOYANG HOSPITAL CAPITAL MEDICAL UNIV +1

A method for detecting chromosomal microdeletions and microduplications in human embryos

The invention relates to a method for detecting chromosome microdeletion and micro-duplication of a human embryo. The method comprises the following steps of performing whole genome amplification on cells cultured in vitro, interrupting DNA (deoxyribonucleic acid) molecules, and sequencing DNA fragments to obtain sequencing reads; comparing the sequencing reads with a reference sequence, and positioning the sequencing reads on the reference sequence; screening non-repeated areas of the reference sequence, and reserving the non-repeated areas; establishing a matrix of read number in windows through normal samples, analyzing the data of the normal samples, performing statistics on the read number of all the windows in the non-repeated areas, and establishing a probability matrix of the read number and chromosome enpeoids; calculating the copy number, i.e., the A / B / C state, of loci; selecting m continuous loci, i.e., the A state, as micro-duplication loci, and selecting m continuous loci, i.e., the C state, as microdeletion loci; contrasting the micro-duplication loci and the microdeletion loci with the existing CNV (copy number variation) and disease database, performing basic gene annotation and gene function analysis which relates to deletion parts, and annotating with a microdeletion syndrome disease type.
Owner:BEIJING ZHONGYI KANGWEI MEDICAL INSTR
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products